-
Conaris develops a new anti-IL-6 fusion protein, which specifically inhibits chronic inflammation (e.g. IBD, arthritis) by blocking IL-6-mediated trans ...
fusion protein gp130 IL-6R Interleukin-6 Interleukin-6 receptor sgp130 sgp130Fc soluble receptor transsignaling trans signaling trans-signaling
www.conaris.de - 2009-02-06
|
depression
prescription
take
discount books
seks
free stuff
reiki
massage
computer books
counseling
mental health
cheap online pharmacy
anxiety
psychotherapy
drawnincest
geil
drug company
massage therapy
freebies
buy prescription drug
fiction books
free
online
fotze
schwanz
freier
shiatsu
neuken
|
|